4126 - 4150 of 9033 Results
Title
Year
-
OPENTitle: Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 23End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7222918Citation Count: 38
-
OPENTitle: Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105221End Page: 105221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.11.013Best OA location URL: http://www.prd-journal.com/article/S1353802022003819/pdfCitation Count: 6
-
OPENTitle: A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100104End Page: 100104Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100104Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100104Citation Count: 24
-
OPENTitle: Synergistic associations of depressive symptoms and aging on cognitive decline in early Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100192End Page: 100192Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100192Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100192Citation Count: 6
-
OPENTitle: Distinct atrophy of septal nuclei in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100171End Page: 100171Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100171Citation Count: 1
-
OPENTitle: Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation AnalysesJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.11.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9106826Citation Count: 19
-
OPENTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 136
-
OPENTitle: Prehospital scales in acute ischaemic stroke management – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 504End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00169-1Best OA location URL: https://pure.eur.nl/en/publications/25abb6f2-0472-4754-8580-97e2533ac37aCitation Count: 1
- Movement disorders research in 2021: cracking the paradigm2021RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 19
- Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study2021RESTRICTEDTitle: Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 53End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00368-9Citation Count: 66
- Revisiting levodopa for advanced Parkinson's disease2022RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 2
- Major advances in Parkinson's disease over the past two decades and future research directions2022RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 17
- Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial2022RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 186
- Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder2022RESTRICTEDTitle: Inconsistency and incongruence: the two diagnostic pillars of functional movement disorderJournal Name: The LancetPublisher: Elsevier BVVol: 400Issue #: 10348Start Page: 328End Page: 328Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(22)01184-9Citation Count: 11
- Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors2022RESTRICTEDTitle: Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursorsJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S88End Page: S89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00209-8Citation Count: 0
- Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein2022RESTRICTEDTitle: Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synucleinJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S87End Page: S88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00207-4Citation Count: 0
- The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A442021RESTRICTEDTitle: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 133Issue #: 1Start Page: 109End Page: 112Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012Citation Count: 3
-
OPENTitle: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 203End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-xBest OA location URL: http://hdl.handle.net/2445/214932Citation Count: 326
-
OPENTitle: Intracellular Thermometry to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 46Issue #: 3Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tibs.2020.12.003Best OA location URL: http://www.cell.com/article/S096800042030308X/pdfCitation Count: 2
-
OPENTitle: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammationJournal Name: Mucosal ImmunologyPublisher: Elsevier BVVol: 14Issue #: 3Start Page: 652End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41385-020-00354-7Best OA location URL: https://www.nature.com/articles/s41385-020-00354-7.pdfCitation Count: 38
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022OPENTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 22
- PINK1/Parkin-Mediated Mitophagy Plays a Protective Role in the Bone Impairment Caused by Aluminum Exposure2021RESTRICTEDTitle: PINK1/Parkin-Mediated Mitophagy Plays a Protective Role in the Bone Impairment Caused by Aluminum ExposureJournal Name: Journal of Agricultural and Food ChemistryPublisher: American Chemical Society (ACS)Vol: 69Issue #: 21Start Page: 6054End Page: 6063Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jafc.1c01921Citation Count: 27
-
OPENTitle: Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gapJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 4Issue #: 11Start Page: e768End Page: e769Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(22)00190-xBest OA location URL: http://www.thelancet.com/article/S258975002200190X/pdfCitation Count: 4
-
OPENTitle: Thyrotoxicosis Resulting in Unilateral Upper Limb Chorea and BallismusJournal Name: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesPublisher: Cambridge University Press (CUP)Vol: 49Issue #: 3Start Page: 431End Page: 432Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/cjn.2021.136Citation Count: 3
-
OPENTitle: The Records of the Human Sciences Research CouncilJournal Name: History in AfricaPublisher: Cambridge University Press (CUP)Vol: 48Issue #:Start Page: 397End Page: 411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/hia.2021.15Citation Count: 1